Vital Signs The Analyst's Perspective - June 2016 Issue

Vital Signs The Analyst's Perspective - June 2016 Issue

RELEASE DATE
02-Aug-2016
REGION
Global
Research Code: 9A35-00-4D-00-00
SKU: HC02668-GL-MR_18826
$450.00
In stock
SKU
HC02668-GL-MR_18826
$450.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

Table of Contents

Related Research
This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-4D-00-00
Is Prebook No